Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
1 to 3 mL per vial is typical
No final FDA action has occurred as of early August 2026, so the timeline for any Category 1 placement remains uncertain and depends on internal agency review, potential public comment, and broader peptide policy under the current administration
This constant presence might be necessary for the ongoing disruption of the FOXO4-p53 interaction in senescent cells, especially if these cells accumulate rapidly
An appointment will be scheduled for you promptly
US$ 24.75
US$ 20.05
US$ 24.70
US$ 24.86
US$ 24.88
US$ 20.49
